![Timothy Stubbs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Stubbs
Directeur/Membre du Conseil chez
BLOSSOMHILL THERAPEUTICS, INC.
Profil
Dr. Timothy Stubbs, MD, is an Independent Director at Blossomhill Therapeutics, Inc. and an Executive Director at Vivo Capital LLC.
He is on the Board of Directors at Blossomhill Therapeutics, Inc. Dr. Stubbs was previously employed as a Vice President by Morgan Stanley.
He received his undergraduate degree from the University of Bristol.
Postes actifs de Timothy Stubbs
| Sociétés | Poste | Début |
|---|---|---|
| BLOSSOMHILL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/03/2024 |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life science sectors. It provides financing for early stage, growth stage, buyouts, spin-offs and restructurings. The firm also acquires controlling interest. It acts as lead investor and also makes co-investments. | Private Equity Investor | 01/03/2022 |
Anciens postes connus de Timothy Stubbs
| Sociétés | Poste | Fin |
|---|---|---|
| MORGAN STANLEY | Corporate Officer/Principal | 01/03/2022 |
Formation de Timothy Stubbs
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Morgan Stanley
 Morgan Stanley Investment ManagersFinance Provides wealth and asset management, trading & investment banking services | Finance |
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life science sectors. It provides financing for early stage, growth stage, buyouts, spin-offs and restructurings. The firm also acquires controlling interest. It acts as lead investor and also makes co-investments. | Finance |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
